Corcept Therapeutics Incorporated (CORT)

Exchange
NASDAQ
Symbol
CORT
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Corcept Therapeutics Incorporated discovers, develops, and markets drugs for the treatment of severe metabolic, cancer, and psychiatric disorders in the United States. The company is headquartered in Menlo Park, California.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    54.08
  • High
    54.88
  • Low
    53.06
  • Close
    54.23
  • Volume
    981,796

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
24.74
Receivables turnover
11.26
Payables turnover
10.99
Working capital turnover
1.36
Days of inventory on hand (DOH)
14.76
Days of sales outstanding (DSO)
32.40
Number of days of payables
33.21
Fixed asset turnover
2,473.72
Total asset turnover
0.78
 Liquidity ratios
Current ratio
4.39
Quick ratio
3.93
Cash ratio
3.52
Cash conversion cycle
13.95
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.23
Interest coverage
—
 Profitability ratios
Gross profit margin
60.36%
Operating profit margin
22.24%
Pretax margin
25.82%
Net profit margin
22.00%
Operating return on assets (Operating ROA)
17.26%
Return on assets (ROA)
17.08%
Return on total capital
21.17%
Return on equity (ROE)
20.95%